{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:37:42Z","timestamp":1790829462699,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH129856"],"award-info":[{"award-number":["R01MH129856"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL156134"],"award-info":[{"award-number":["R01HL156134"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA037801"],"award-info":[{"award-number":["T32DA037801"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K24 DA050087"],"award-info":[{"award-number":["K24 DA050087"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1038\/s41380-023-02049-4","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T10:09:24Z","timestamp":1681726164000},"page":"2462-2468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The impact of preexisting psychiatric disorders and antidepressant use on COVID-19 related outcomes: a multicenter study"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5085-8249","authenticated-orcid":false,"given":"Katharina","family":"Schultebraucks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wivine","family":"Blekic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cale","family":"Basaraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Corbeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandy F.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca D.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennett","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Arout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold Alan","family":"Pincus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances R.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"2049_CR1","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S0140-6736(20)30460-8","volume":"395","author":"SK Brooks","year":"2020","unstructured":"Brooks SK. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912\u201320.","journal-title":"Lancet"},{"key":"2049_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1017\/S0033291721000015","volume":"51","author":"G Prati","year":"2021","unstructured":"Prati G, Mancini AD. The psychological impact of COVID-19 pandemic lockdowns: a review and meta-analysis of longitudinal studies and natural experiments. Psychol Med. 2021;51:201\u201311.","journal-title":"Psychol Med"},{"key":"2049_CR3","doi-asserted-by":"publisher","first-page":"12728","DOI":"10.1002\/emp2.12728","volume":"3","author":"DL Sacco","year":"2022","unstructured":"Sacco DL, Probst MA, Schultebraucks K, Greene MC, Chang BP. Evaluation of emergency department visits for mental health complaints during the COVID\u201019 pandemic. J Am Coll Emerg Physicians Open. 2022;3:12728.","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"2049_CR4","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1056\/NEJMp2008017","volume":"383","author":"B Pfefferbaum","year":"2020","unstructured":"Pfefferbaum B, North CS. Mental health and the Covid-19 pandemic. N Engl J Med. 2020;383:510\u20132.","journal-title":"N Engl J Med"},{"key":"2049_CR5","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","volume":"398","author":"DF Santomauro","year":"2021","unstructured":"Santomauro DF. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398:1700\u201312.","journal-title":"Lancet."},{"key":"2049_CR6","doi-asserted-by":"publisher","first-page":"798554","DOI":"10.3389\/fpsyt.2021.798554","volume":"12","author":"M De Hert","year":"2022","unstructured":"De Hert M, Mazereel V, Stroobants M, De Picker L, Van Assche K, Detraux J. COVID-19-related mortality risk in people with severe mental illness: a systematic and critical review. Front Psychiatry. 2022;12:798554.","journal-title":"Front Psychiatry"},{"key":"2049_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/jamapsychiatry.2021.1818","volume":"78","author":"F Ceban","year":"2021","unstructured":"Ceban F, Nogo D, Carvalho IP, Lee Y, Nasri F, Xiong J, et al. Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: a systematic review and meta-analysis. JAMA Psychiatry. 2021;78:1079.","journal-title":"JAMA Psychiatry"},{"key":"2049_CR8","doi-asserted-by":"publisher","first-page":"609579","DOI":"10.3389\/fpsyt.2020.609579","volume":"11","author":"M Maripuu","year":"2021","unstructured":"Maripuu M, Bendix M, \u00d6hlund L, Widerstr\u00f6m M, Werneke U. Death associated with coronavirus (COVID-19) infection in individuals with severe mental disorders in Sweden during the early months of the outbreak\u2014an exploratory cross-sectional analysis of a population-based register study. Front Psychiatry. 2021;11:609579.","journal-title":"Front Psychiatry"},{"key":"2049_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S2215-0366(21)00232-7","volume":"8","author":"B Vai","year":"2021","unstructured":"Vai B, Mazza MG, Delli Colli C, Foiselle M, Allen B, Benedetti F, et al. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis. Lancet Psychiatry. 2021;8:797\u2013812.","journal-title":"Lancet Psychiatry"},{"key":"2049_CR10","doi-asserted-by":"publisher","first-page":"101111","DOI":"10.1016\/j.eclinm.2021.101111","volume":"40","author":"L Liu","year":"2021","unstructured":"Liu L, Ni S-Y, Yan W, Lu Q-D, Zhao Y-M, Xu Y-Y, et al. Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: a systematic review, meta-analysis and call for action. eClinicalMedicine. 2021;40:101111.","journal-title":"eClinicalMedicine"},{"key":"2049_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jad.2021.10.024","volume":"297","author":"X Dai","year":"2022","unstructured":"Dai X, Shao Y, Ren L, Tao W, Wang Y. Risk factors of COVID-19 in subjects with and without mental disorders. J Affect Disord. 2022;297:102\u201311.","journal-title":"J Affect Disord"},{"key":"2049_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/acps.13309","volume":"144","author":"CA Barcella","year":"2021","unstructured":"Barcella CA, Polcwiartek C, Mohr GH. Severe mental illness is associated with increased mortality and severe course of COVID-19. Acta Psychiatr Scand. 2021;144:82\u201391.","journal-title":"Acta Psychiatr Scand"},{"key":"2049_CR13","doi-asserted-by":"publisher","first-page":"113856","DOI":"10.1016\/j.psychres.2021.113856","volume":"299","author":"AA Toubasi","year":"2021","unstructured":"Toubasi AA, AbuAnzeh RB, Tawileh HBA. A meta-analysis: the mortality and severity of COVID-19 among patients with mental disorders. Psychiatry Res. 2021;299:113856.","journal-title":"Psychiatry Res"},{"key":"2049_CR14","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1192\/bjo.2021.1046","volume":"7","author":"S Chen","year":"2021","unstructured":"Chen S, Fernandez-Egea E, Jones PB. Longer-term mortality following SARS-CoV-2 infection in people with severe mental illness: retrospective case-matched study. BJPsych Open. 2021;7:e201.","journal-title":"BJPsych Open"},{"key":"2049_CR15","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S2215-0366(20)30421-1","volume":"7","author":"SW Lee","year":"2020","unstructured":"Lee SW, Yang JM, Moon SY, Yoo IK, Ha EK, Kim SY, et al. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study. Lancet Psychiatry. 2020;7:1025\u201331.","journal-title":"Lancet Psychiatry"},{"key":"2049_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01325-7","volume":"11","author":"JJ Luykx","year":"2021","unstructured":"Luykx JJ, Lin BD. Are psychiatric disorders risk factors for COVID-19 susceptibility and severity? a two-sample, bidirectional, univariable, and multivariable Mendelian Randomization study. Transl Psychiatry. 2021;11:210.","journal-title":"Transl Psychiatry"},{"key":"2049_CR17","doi-asserted-by":"crossref","unstructured":"Nakhaee H, Bayati R, Rahmanian M, Jolfayi AG, Zangiabadian M, Rakhshanderou S. The effect of antidepressants on severity of COVID-19 in hospitalized patients: a systematic review and meta-analysis. Psychiatry Clin Psychol. 2022;17:e0267423.","DOI":"10.1371\/journal.pone.0267423"},{"key":"2049_CR18","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1038\/s41380-021-01021-4","volume":"26","author":"N Hoertel","year":"2021","unstructured":"Hoertel N, S\u00e1nchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021;26:5199\u2013212.","journal-title":"Mol Psychiatry"},{"key":"2049_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/acps.13304","volume":"143","author":"C Diez\u2010Quevedo","year":"2021","unstructured":"Diez\u2010Quevedo C, Iglesias\u2010Gonz\u00e1lez M, Giralt\u2010L\u00f3pez M, Rangil T, Sanagustin D, Moreira M, et al. Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID\u201019 Spanish inpatients. Acta Psychiatr Scand. 2021;143:526\u201334.","journal-title":"Acta Psychiatr Scand"},{"key":"2049_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573\u20137.","journal-title":"Ann Intern Med"},{"key":"2049_CR21","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1007\/s11606-022-07610-5","volume":"37","author":"C-W Huang","year":"2022","unstructured":"Huang C-W. Disease-specific factors associated with readmissions or mortality after hospital discharge in COVID-19 patients: a retrospective cohort study. J Gen Intern Med. 2022;37:3973\u20138.","journal-title":"J Gen Intern Med"},{"key":"2049_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/all.14657","volume":"76","author":"Y Gao","year":"2021","unstructured":"Gao Y, Ding M, Dong X, Zhang J, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy 2021;76:428\u201355.","journal-title":"Allergy"},{"key":"2049_CR23","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/jmv.26424","volume":"93","author":"J Li","year":"2021","unstructured":"Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, et al. Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93:1449\u201358.","journal-title":"J Med Virol"},{"key":"2049_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/aje\/kwt212","volume":"179","author":"M Lunt","year":"2014","unstructured":"Lunt M. Selecting an appropriate caliper can be essential for achieving good balance with propensity score matching. Am J Epidemiol. 2014;179:226\u201335.","journal-title":"Am J Epidemiol"},{"key":"2049_CR25","unstructured":"Cochran WG, Rubin DB. Controlling bias in observational studies: a review. Sankhy\u0101. Indian J Stat. 1973;Series A, 35:417\u201346."},{"key":"2049_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity\u2010score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150\u201361.","journal-title":"Pharm Stat"},{"key":"2049_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-70","volume":"12","author":"R Pirracchio","year":"2012","unstructured":"Pirracchio R, Resche-Rigon M, Chevret S. Evaluation of the Propensity score methods for estimating marginal odds ratios in case of small sample size. BMC Med Res Methodol. 2012;12:70.","journal-title":"BMC Med Res Methodol"},{"key":"2049_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/jamapsychiatry.2020.4442","volume":"78","author":"K Nemani","year":"2021","unstructured":"Nemani K, Li C, Olfson M, Blessing EM, Razavian N, Chen J, et al. Association of psychiatric disorders with mortality among patients with COVID-19. JAMA Psychiatry. 2021;78:380.","journal-title":"JAMA Psychiatry"},{"key":"2049_CR29","doi-asserted-by":"crossref","unstructured":"Hoertel N, S\u00e1nchez-Rico M, de la Muela P, Abell\u00e1n M, Blanco C, Leboyer M, et al. Risk of death in individuals hospitalized for COVID-19 with and without psychiatric disorders: an observational multicenter study in France. Biol Psychiatry Glob Open Sci. 2022;3:56\u201367.","DOI":"10.1016\/j.bpsgos.2021.12.007"},{"key":"2049_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000365542","volume":"179","author":"N M\u00fcller","year":"2014","unstructured":"M\u00fcller N. Infectious diseases and mental health. Comorb Ment Phys Disord. 2014;179:99\u2013113.","journal-title":"Comorb Ment Phys Disord"},{"key":"2049_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/10538712.2019.1709242","volume":"29","author":"O Maalouf","year":"2020","unstructured":"Maalouf O, Daigneault I, Dargan S, McDuff P, Frappier JY. Relationship between child sexual abuse, psychiatric disorders and infectious diseases: a matched-cohort study. J Child Sex Abus. 2020;29:749\u201368.","journal-title":"J Child Sex Abus"},{"key":"2049_CR32","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1136\/bmj.l5784","volume":"367","author":"H Song","year":"2019","unstructured":"Song H, Fall K, Fang F, Erlendsd\u00f3ttir H, Lu D, Mataix-Cols D, et al. Stress related disorders and subsequent risk of life threatening infections: population based sibling controlled cohort study. BMJ. 2019;367:5784.","journal-title":"BMJ."},{"key":"2049_CR33","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/S2666-7568(20)30013-1","volume":"1","author":"H Yang","year":"2020","unstructured":"Yang H, Chen W, Hu Y, Chen Y, Zeng Y, Sun Y, et al. Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis. Lancet Healthy Longev. 2020;1:e69\u2013e79.","journal-title":"Lancet Healthy Longev"},{"key":"2049_CR34","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1073\/pnas.1531903100","volume":"100","author":"JK Kiecolt-Glaser","year":"2003","unstructured":"Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 2003;100:9090\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2049_CR35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.biopsych.2008.03.017","volume":"64","author":"GE Miller","year":"2008","unstructured":"Miller GE, Chen E, Sze J, Marin T, Arevalo JMG, Doll R, et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-\u03baB signaling. Biol Psychiatry. 2008;64:266\u201372.","journal-title":"Biol Psychiatry"},{"key":"2049_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41380-021-01117-x","volume":"27","author":"K Yuan","year":"2022","unstructured":"Yuan K. A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. Mol Psychiatry. 2022;27:1\u20139.","journal-title":"Mol Psychiatry"},{"key":"2049_CR37","doi-asserted-by":"crossref","unstructured":"Hashimoto Y, Suzuki T, Hashimoto K. Mechanisms of action of fluvoxamine for COVID-19: a historical review. Mol Psychiatry. 2021;27:1898\u2013907.","DOI":"10.1038\/s41380-021-01432-3"},{"key":"2049_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/npr2.12194","volume":"41","author":"CKS Meikle","year":"2021","unstructured":"Meikle CKS, Creeden JF, McCullumsmith C, Worth RG. SSRIs: applications in inflammatory lung disease and implications for COVID\u201019. Neuropsychopharmacol Rep. 2021;41:325\u201335.","journal-title":"Neuropsychopharmacol Rep"},{"key":"2049_CR39","doi-asserted-by":"publisher","first-page":"110140","DOI":"10.1016\/j.mehy.2020.110140","volume":"144","author":"MGM Hamed","year":"2020","unstructured":"Hamed MGM, Hagag RS. The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients. Med Hypotheses. 2020;144:110140.","journal-title":"Med Hypotheses"},{"key":"2049_CR40","unstructured":"New York State Behavioral Risk Factor Surveillance System. Prevalence of obesity among New York State Adults by county, BRFSS 2018. Centers for Disease Control and Prevention (CDC); 2021."},{"key":"2049_CR41","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/ajmg.b.32548","volume":"177","author":"JW Smoller","year":"2018","unstructured":"Smoller JW. The use of electronic health records for psychiatric phenotyping and genomics. Am J Med Genet Part B: Neuropsychiatr Genet. 2018;177:601\u201312.","journal-title":"Am J Med Genet Part B: Neuropsychiatr Genet"},{"key":"2049_CR42","doi-asserted-by":"publisher","first-page":"30564","DOI":"10.2196\/30564","volume":"8","author":"Y Zurynski","year":"2021","unstructured":"Zurynski Y. Implementation of electronic medical records in mental health settings: scoping review. JMIR Ment Health. 2021;8:30564.","journal-title":"JMIR Ment Health"},{"key":"2049_CR43","doi-asserted-by":"publisher","first-page":"30405","DOI":"10.2196\/30405","volume":"24","author":"TC Kariotis","year":"2022","unstructured":"Kariotis TC, Prictor M, Chang S, Gray K. Impact of electronic health records on information practices in mental health contexts: scoping review. J Med Internet Res. 2022;24:30405.","journal-title":"J Med Internet Res"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02049-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02049-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02049-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T08:05:19Z","timestamp":1698393919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02049-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2049"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-02049-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"18 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This publication was supported by the National Center for Advancing Translational Sciences (UL1TR001873). KSs received support from the National Institute of Mental Health (R01MH129856) and the National Heart, Lung, and Blood Institute (R01HL156134). BA received support from the National Institute on Drug Abuse (T32 DA007233). BFH received support from the National Institute on Drug Abuse (T32DA037801). FRL receives grant support from the NIDA, NCATS, SAMHSA, US World Meds and research support from Aelis Pharmaceuticals. She also receives medication from Indivior for research and royalties from APA publishing. In addition, FRL served as a nonpaid member of a Scientific Advisory Board for Alkermes, Indivior, Novartis, Teva, and US WorldMeds and is a consultant to Major League Baseball. DM received support from the National Institute on Drug Abuse (K24 DA050087). HAP is employed by Columbia University, New York State Office of Mental Health\/Research, Foundation for Mental Hygiene, and RAND Corporation (Adjunct Staff). All research and training projects funded by not for profit or public sources. He has served on clinical advisory committees for AbleTo, Cerebral and Magellan Studio. NK is involved in ongoing opioid litigation. All other authors report no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}